Wordt geladen...
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Tremendous efforts have been made over the past few decades to discover novel cancer biomarkers for use in clinical practice. However, a striking discrepancy exists between the effort directed toward biomarker discovery and the number of markers that make it into clinical practice. One of the confou...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3850675/ https://ncbi.nlm.nih.gov/pubmed/24088261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1559-0275-10-13 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|